North Florida Foundation for Research and Education Inc.
North Florida Foundation for Research and Education Inc.
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for North Florida Foundation for Research and Education Inc.? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
NFFRE FACILITATES MEDICAL RESEARCH AND EDUCATION PROJECTS AT THE NORTH FLORIDA/SOUTH GEORGIA VETERANS HEALTH SYSTEM (VA) UNDER THE AUTHORITY OF TITLE 38 USC SECTIONS 7361-7366.
About
A NONPROFIT VA RESEARCH AND EDUCATION FOUNDATION, THE NORTH FLORIDA FOUNDATION FOR RESEARCH AND EDUCATION, INC. (NFFRE) WAS ESTABLISHED TO ADMINISTER AND FACILITATES RESEARCH AND EDUCATION PROGRAMS WITHIN THE NORTH FLORIDA/SOUTH GEORGIA VETERANS HEALTH SYSTEM (NF/SGVHS) LOCATED IN GAINESVILLE FLORIDA. RESEARCHERS AT THE NF/SGVHS CONDUCT INVESTIGATOR- INITIATED AND PHARMACEUTICAL/DEVICE SPONSOR INITIATED TRIALS. NFFRE BENEFITS VA HEALTH CARE AND STRIVES TO PROVIDE SUPPORT AND FLEXIBLE FUNDING MECHANISMS TO SUPPORT VA RESEARCHERS AND COLLABORATORS WHILE OFFERING ADDITIONAL OPPORTUNITIES FOR OUR VETERANS TO PARTICIPATE IN CLINICAL TRIALS. OUR RESEARCH IS DEDICATED TO INVESTIGATING A VARIETY OF AILMENTS AFFLICTING THE NATION'S VETERANS. NFFRE PLAYS AN IMPORTANT ROLE SUPPORTING VA INVESTIGATORS AND SERVES TO FACILITATE COLLABORATIVE EFFORTS WITH INDUSTRY SPONSORS, ACADEMIC INSTITUTIONS, OTHER FEDERAL AGENCIES, VOLUNTARY HEALTH ORGANIZATIONS, NONPROFIT PROFESSIONAL SOCIETIES, AND FOR-PROFIT COMPANIES TO CONDUCT CLINICAL TRIALS, TEST THERAPEUTIC INTERVENTIONS, SUPPORT LAB BASED PROJECTS AND COLLECT DATA FOR OUTCOMES PROJECTS. A FEW EXAMPLES OF NFFRE'S CONTRIBUTIONS TO VA RESEARCH AND VA EDUCATION AT NF/SGVHS: DURING FISCAL YEAR 2018, NFFRE FOSTERED MANY SPONSORED STUDIES CONDUCTED AT NF/SGVHS WITH INDUSTRY COLLABORATORS INCLUDING NOVARTIS, ENDOCYTE, GLAXO SMITH KLINE, RTI SURGICAL, ASTRAZENECA, ENDOLOGIX, SANOFI, GILEAD SCIENCES, ENDOLOGIX, BIOMONDE, CELGENE, PFIZER, CIRIUS, AMGEN, POPULATION HEALTH RESEARCH INSTITUTE, PHILIPS RESPIRONICS, AND. NFFRE MANAGED OVER 30 ACTIVE CRADAS AND INITIATED 5 NEW CRADAS (VA COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENTS). NFFRE PROVIDES RESEARCH SUPPORT FOR GARY WANG, MD WHO SPECIALIZES IN INFECTIOUS DISEASE AT NF/SGVHS. ONE OF HIS CURRENT STUDIES, CLOVER, IS INVESTIGATING A PROPHYLACTIC VACCINE CALLED CLOSTRIDIUM DIFFICILE FOR PREVENTION OF PRIMARY C DIFFICILE INFECTION (CDI) IN ADULTS FIFTY YEARS OF AGE AND OLDER. CDI CAN CAUSE MILD TO SEVERE DIARRHEA AND DISCOMFORT AND EVEN DEATH IN SEVERE CASES. APPROXIMATELY 16% TO 35% OF HOSPITAL INPATIENTS ARE CARRIERS OF CDI AND THE NUMBERS ARE INCREASING YEARLY. TO DATE, THE ONLY MEASURES AVAILABLE TO HELP PREVENT CDI ARE BEHAVIORAL ONES SUCH AS ENCOURAGING APPROPRIATE USE OF ANTIMICROBIALS, USE OF CONTACT PRECAUTIONS, AND CLEANING AND DISINFECTION OF EQUIPMENT AND THE ENVIRONMENT. THIS RESEARCH IS HOPING TO DEMONSTRATE THAT THE VACCINE IS EFFECTIVE IN REDUCING THE FIRST INCIDENCE OF CDI. SO FAR, OUR SITE HAS ENROLLED 50 PATIENTS. PERUVEMBA SRIRAM, MD IS THE CHIEF OF PULMONARY AT NF/SGVHS. HE IS RESEARCHING THE USE OF INFLUENZA VACCINE BEING ASSOCIATED WITH LOWER RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE). INFLUENZA INFECTION IS KNOWN TO BE ASSOCIATED WITH INCREASED RISK OF CARDIOVASCULAR (CV) EVENTS. SEVERAL LINES OF INVESTIGATION SUGGEST THAT INFLUENZA VACCINE MIGHT ATTENUATE CARDIAC RISK IN HIGH-RISK POPULATIONS. HOWEVER, INFLUENZA VACCINE IS WIDELY AND PROFOUNDLY UNDERUTILIZED IN THIS POPULATION. THIS TRIAL, IF POSITIVE, HAS THE POTENTIAL TO SUBSTANTIALLY IMPACT A MAJOR POPULATION ATTRIBUTABLE CV RISK, CHANGE PRACTICE, AND INFORM HEALTH POLICY BY BOOSTING UTILIZATION OF INFLUENZA VACCINATION.
Interesting data from their 2019 990 filing
The filing clearly states the mission of the non-profit as “Nffre supports va medical research and va education at the north florida/south georgia veterans health system (va) under the authority of title 38 usc sections 7361-7366.”.
When outlining its functions, they were explained as: “Nffre facilitates medical research and education projects at the north florida/south georgia veterans health system (va) under the authority of title 38 usc sections 7361-7366.”.
- In compliance with legal regulations, the non-profit has reported their state of operation as FL.
- The filing records the non-profit's address for 2019 as 1601 SW ARCHER ROAD 151, GAINESVILLE, FL, 32608.
- As of 2019, the non-profit's form reports a total of 27 employees.
- Does not operate a hospital.
- Does not operate a school.
- Does not collect art.
- Does not provide credit counseling.
- Does not have foreign activities.
- Is not a donor-advised fund.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $694,391.
- The CEO's salary plan within the organization is subject to review and endorsement by an independent body.
- The organization has a written policy that describes how long it will retain documents.
- The organization has 2 independent voting members.
- The organization was formed in 1997.
- The organization has a written policy that addresses conflicts of interest.
- The organization is required to file Schedule O.
- The organization pays $732,936 in salary, compensation, and benefits to its employees.
- The organization pays $244 in fundraising expenses.
- The organization has minutes of its meetings.
- The organization has a written whistleblower policy.
- The organization's financial statements were reviewed by an accountant.